#European cannabis
#European cannabis · page 5
- CBD Market
European Commission Validates Five Natural Plant CBD Novel Food Applications In Milestone For Industry
FEARS the European Commission will once more change its position on the status of CBD have receded after it Validated its first Novel Food applications for natural plant extracts.
- CBD Market
European Cannabis Round-Up: Italy’s Highest Court Blocks Cannabis Reform, Swiss CBD Scandal, Swedish Hemp, Portugal, Germany And The UK
A BID to hold a national referendum to legalise the cultivation of cannabis for personal use in Italy has been blocked by the country’s highest court.
- Press releases
Cannovum Launches Cannabis Medical Education Platform
CANNOVUM AG (stock exchanges Düsseldorf, Munich, Hamburg, Berlin, gettex: ISIN DE000A2LQU21) announces the launch of its Medical Education Platform (CME).
- Press releases
Canxchange Announces Entry Into The Medical Cannabis Sector In Strategic Partnership With EPC Healthcare
CANXCHANGE, the leading physical Cannabis exchange, will now operate within the medicinal cannabis sector.
- News
DanCann’s £1m Cash Boost Following £1.5m CannGros Purchase Aims To Boost Its European Ambitions
DANISH medical cannabis company DanCann Pharma has raised a further £1m-plus from shareholders as it looks to bring its first commercial products to the market in the second half of 2022.
- CBD Market
By Treating CBD Flowers As A Tobacco Product Has Belgium Established A Pathway For Other European Countries To Follow?
While the French government is trying to outlaw CBD flowers, its northern neighbour is a European leader in the market as Françoise Martin, of Buddy Belgium explains.
- Medical
New UK Government Efforts To Boost Medical Cannabis Access Met With Muted Response
THE Government has eventually responded to a report into the progress of the UK’s medical cannabis prescribing regime – over one year since it was submitted.
- Adult-Use
European Cannabis Round-Up: Germany’s Adult-use Ambitions And Challenges With The New Drugs Czar And The Business Community
GERMANY’S new Drug Commissioner has spoken at length of the country’s moves to introduce an adult-use cannabis market and how it is set to write a new chapter in European history.
- Press releases
Alpha Blue Ocean and Óskare Capital Announce Partnership
ALPHA Blue Ocean (ABO) and Óskare Capital are announcing today the formation of a strategic partnership to collaborate on investment opportunities associated with cannabis plant-based medicines as well as synthetic molecules that target the mammalian Endocannabinoid system (ECS).
- Press releases
Panaxia And Neuraxpharm: First Export Of Medical Cannabis Sublingual Tablets To France
The first-of-its-kind export is part of the companies’ participation in the French government’s program to regulate the medical cannabis industry Both companies have previously issued their premium oils to patients in France PANAXIA Labs Israel Ltd (TASE: PNAX), a global pharma company which develops, manufactures and markets progressive medical cannabis products in pharmaceutical quality, and Neuraxpharm…
- Adult-Use
Bloomwell’s $10m Cash Boost To Support Preparations For Germany’s Adult-Use Market
LEADING German medical cannabis healthcare company The Bloomwell Group, is preparing for a major push into the recreational market – and believes its peers would be ‘foolish’ not to.
- Press releases
DEMECAN Receives GMP Certificate For Cannabis Production Facility
*Saxony Awards Manufacturing Licence For Medical Cannabis*DEMECAN ensures compliance with highest quality criteria*Way cleared for first cannabis flower delivery “Made in Saxony” DEMECAN, the only independent German producer of medicinal cannabis, has been granted a manufacturing license in accordance with §13 AMG (German Medicines Act) and GMP (Good Manufacturing Practice) certification for its production facility…
